Merro Pharmaceutical
Where We Are   Dalian The most developed industrial and commercial hub in Northeast China China Main Shipping Port with 1-2 hours flight away from Beijing, Shanghai, Tokyo and Seoul
Who We Are Merro Pharmaceutical Co., Ltd is the leading manufacturer,  wholesaler and retailer of prescription drugs (Rx), non-prescription drugs (OTC) and nutritional supplements in China. Employees :  3100 Area: 150,000 sq meter Sales  Revenue :  $ 142 million  Total Assets: $ 139 million  Net Assets:  $  65  million    -  Up to FY 2006
TIMELINE & MAIN EVENTS 1925  Founded as Dalian Manie Health Research  Institute  1958  First antibiotics manufacturer in China,  Pioneering in Erythromycin development and  manufacturing 1992  Formed Joint-Venture with Pfizer in China 1997  New Era - Merro Pharmaceutical Group 2000  Went public (in Shanghai Stock Exchange) 2003  Bought over China’s largest Traditional  Medicinal Factory in Dalian;
How We Are Structured Merro Pharmaceutical Co., Ltd Merro Pharmaceutical Factory Merro Traditional Medicine Factory Merro Marketing & Distribution R&D Manufacturing Quality Purchasing Sales Business Development
Site Map
Sales Record $142 Million  –  FY 2006
 
 
Manufacturing Capacity Tablet  - 1.5 billion (to be doubled in 6months)  Hard capsules  -  1 billion Oral Powder - 100 millions satchet Lyophilized vials  -  4 millions Eye drop solution -  10 millions units Powder for injections  - 300 millions bottles Oral solutions -  50 millions bottles Pellets -  200 millions
Major Regulatory Approvals & Audits Chinese GMP approval  - 2000 Australian TGA approval (one of the first 4 out of China) - 2005 Leiner’s Audit  - 2006 Sigfried’s Audit  - 2006 Australian TGA re-inspection approval - 2006 Arrow’s Audit - 2006 Japan Generics’ Audit - 2007 Ratiopharm’s Audit  - 2007
Chronology of Communications with   Leiner Health Products Visits to Leiner - 2005, 2006, 2007 Leiner’s audit – 07/2007 Meeting at CPhI Paris 2006 - Roadmap for 6 OTC products APAP APAP PM Diphenhydramine (capsules & tablets) Aspirin 81mg Aspirin 325mg Prices last updated 07/2007 R&D samples tested and rated by Schuster as 10
Working with some leading generic companies in the world since 2003 Currently contract manufacturing 3 products for Australia and New Zealand Developed and ready to sell 9 products to Australia, Japan and Europe Work in process for the first ANDA to be filed in 2009.   Embark On International Ventures
Why Merro   -  A first class partner for outsourced products Solid technical and manufacturing experience for cross-board products A top-notch cGMP level  Manufacturing capability Proven commercial success Familiarity with business model and respect of the relationship with partners Vision into the future and long-term commitment
Merro’s Vision Become the worldwide partner for Chinese domestic and overseas markets, including U.S. market. -  Build US presence through Merro Pharmaceutical Corp. - Expand Product Portfolio, including multi ANDAs in    phase development. - reinforce the personnel (R&D and Corporate) to secure   the sustained development that a leading pharmaceutical    firm has to have.
MERRO PHARMACETUICAL  Existing only For Health

More Related Content

PDF
Director of Sales - Consumer Heath Care - Strides Shasun INC. USA
PPTX
swot of sun pharma
PPTX
Ranbaxy
DOCX
B2 novartis
PPTX
Sun Pharma Vs Lupin Pharma
PPT
Lupin Corporate Small
Director of Sales - Consumer Heath Care - Strides Shasun INC. USA
swot of sun pharma
Ranbaxy
B2 novartis
Sun Pharma Vs Lupin Pharma
Lupin Corporate Small

What's hot (15)

PPTX
Top 10 pharma manufacturers in baddi
PPTX
Sun Pharma Vs Lupin Pharma
PPTX
Ranbaxy crisis
PPTX
Novartis india
PPT
West Coast Pharmaceutical Works Ltd
PPTX
PPTX
Pharma third party manufacturing companies in Baddi | Pharmaadda
PPTX
Top 10 Pharma Companies in Vadodara | Pharmaadda
PDF
Pab organics-private-limited
PDF
Nutraceutical business one stop solution
PDF
Manufacturing Facilities | Private Label | Contract | Ointment Manufacturer |...
PPTX
Cipla Presentation
PDF
Research Report on Cipla Limited
DOCX
Marketing Research Project
DOCX
Orchid pharma portfolio management
Top 10 pharma manufacturers in baddi
Sun Pharma Vs Lupin Pharma
Ranbaxy crisis
Novartis india
West Coast Pharmaceutical Works Ltd
Pharma third party manufacturing companies in Baddi | Pharmaadda
Top 10 Pharma Companies in Vadodara | Pharmaadda
Pab organics-private-limited
Nutraceutical business one stop solution
Manufacturing Facilities | Private Label | Contract | Ointment Manufacturer |...
Cipla Presentation
Research Report on Cipla Limited
Marketing Research Project
Orchid pharma portfolio management
Ad

Similar to Merros Presentation (20)

PPT
PPTX
Ranbaxycompanyprofile
PDF
company profile for Weierli Group
PDF
Nutriband Inc. 2021 Deck
PDF
Nutraceutical business one stop solution
PPTX
Ranbaxy company profile
PPT
Aurobindo pharma ltd generic licensing
PPTX
Competitive Analysis of Abbott Laboratories
PDF
Introduction of BrightGene-Abby
PPTX
Rishabh presentation.pptx
DOCX
Company profile of ranbaxy
PDF
Mp advisors sa deals 2013.pdf
PDF
Sanmour Pharma - Ram Gulwady CV
PDF
Pharmaceutical Marketing: An Analysis of the Pharmaceutical Industry in Bangl...
PPTX
List of pharma companies in Indore | Pharmaadda
PPTX
Zee Laboratories Group.pptx
DOCX
Assignment
DOC
Updated Profile Ilyas
DOC
Curriculum Vitae-Urs Flueckiger OM152
DOC
45337850 mgt-company-analysis-beximco-pharma
Ranbaxycompanyprofile
company profile for Weierli Group
Nutriband Inc. 2021 Deck
Nutraceutical business one stop solution
Ranbaxy company profile
Aurobindo pharma ltd generic licensing
Competitive Analysis of Abbott Laboratories
Introduction of BrightGene-Abby
Rishabh presentation.pptx
Company profile of ranbaxy
Mp advisors sa deals 2013.pdf
Sanmour Pharma - Ram Gulwady CV
Pharmaceutical Marketing: An Analysis of the Pharmaceutical Industry in Bangl...
List of pharma companies in Indore | Pharmaadda
Zee Laboratories Group.pptx
Assignment
Updated Profile Ilyas
Curriculum Vitae-Urs Flueckiger OM152
45337850 mgt-company-analysis-beximco-pharma
Ad

Recently uploaded (20)

PPTX
33ABJFA6556B1ZP researhchzfrsdfasdfsadzd
PDF
Stacey L Stevens - Canada's Most Influential Women Lawyers Revolutionizing Th...
PDF
Engaging Stakeholders in Policy Discussions: A Legal Framework (www.kiu.ac.ug)
PDF
Highest-Paid CEO in 2025_ You Won’t Believe Who Tops the List.pdf
PPTX
BUSINESS CYCLE_INFLATION AND UNEMPLOYMENT.pptx
PDF
Middle East's Most Impactful Business Leaders to Follow in 2025
PPTX
IITM - FINAL Option - 01 - 12.08.25.pptx
PDF
Value-based IP Management at Siemens: A Cross-Divisional Analysis
PDF
Second Hand Fashion Call to Action March 2025
DOCX
Handbook of Entrepreneurship- Chapter 5: Identifying business opportunity.docx
PDF
Sustainable Digital Finance in Asia_FINAL_22.pdf
PPTX
operations management : demand supply ch
PPTX
Portfolio Example- Market & Consumer Insights – Strategic Entry for BYD UK.pptx
DOCX
Center Enamel A Strategic Partner for the Modernization of Georgia's Chemical...
PPTX
CTG - Business Update 2Q2025 & 6M2025.pptx
PDF
Comments on Clouds that Assimilate Parts I&II.pdf
DOCX
Hand book of Entrepreneurship 4 Chapters.docx
PDF
533158074-Saudi-Arabia-Companies-List-Contact.pdf
PPTX
TRAINNING, DEVELOPMENT AND APPRAISAL.pptx
PPTX
df0ee68f89e1a869be4bff9b80a7 business 79f0.pptx
33ABJFA6556B1ZP researhchzfrsdfasdfsadzd
Stacey L Stevens - Canada's Most Influential Women Lawyers Revolutionizing Th...
Engaging Stakeholders in Policy Discussions: A Legal Framework (www.kiu.ac.ug)
Highest-Paid CEO in 2025_ You Won’t Believe Who Tops the List.pdf
BUSINESS CYCLE_INFLATION AND UNEMPLOYMENT.pptx
Middle East's Most Impactful Business Leaders to Follow in 2025
IITM - FINAL Option - 01 - 12.08.25.pptx
Value-based IP Management at Siemens: A Cross-Divisional Analysis
Second Hand Fashion Call to Action March 2025
Handbook of Entrepreneurship- Chapter 5: Identifying business opportunity.docx
Sustainable Digital Finance in Asia_FINAL_22.pdf
operations management : demand supply ch
Portfolio Example- Market & Consumer Insights – Strategic Entry for BYD UK.pptx
Center Enamel A Strategic Partner for the Modernization of Georgia's Chemical...
CTG - Business Update 2Q2025 & 6M2025.pptx
Comments on Clouds that Assimilate Parts I&II.pdf
Hand book of Entrepreneurship 4 Chapters.docx
533158074-Saudi-Arabia-Companies-List-Contact.pdf
TRAINNING, DEVELOPMENT AND APPRAISAL.pptx
df0ee68f89e1a869be4bff9b80a7 business 79f0.pptx

Merros Presentation

  • 2. Where We Are Dalian The most developed industrial and commercial hub in Northeast China China Main Shipping Port with 1-2 hours flight away from Beijing, Shanghai, Tokyo and Seoul
  • 3. Who We Are Merro Pharmaceutical Co., Ltd is the leading manufacturer, wholesaler and retailer of prescription drugs (Rx), non-prescription drugs (OTC) and nutritional supplements in China. Employees : 3100 Area: 150,000 sq meter Sales Revenue : $ 142 million Total Assets: $ 139 million Net Assets: $ 65 million - Up to FY 2006
  • 4. TIMELINE & MAIN EVENTS 1925 Founded as Dalian Manie Health Research Institute 1958 First antibiotics manufacturer in China, Pioneering in Erythromycin development and manufacturing 1992 Formed Joint-Venture with Pfizer in China 1997 New Era - Merro Pharmaceutical Group 2000 Went public (in Shanghai Stock Exchange) 2003 Bought over China’s largest Traditional Medicinal Factory in Dalian;
  • 5. How We Are Structured Merro Pharmaceutical Co., Ltd Merro Pharmaceutical Factory Merro Traditional Medicine Factory Merro Marketing & Distribution R&D Manufacturing Quality Purchasing Sales Business Development
  • 7. Sales Record $142 Million – FY 2006
  • 8.  
  • 9.  
  • 10. Manufacturing Capacity Tablet - 1.5 billion (to be doubled in 6months) Hard capsules - 1 billion Oral Powder - 100 millions satchet Lyophilized vials - 4 millions Eye drop solution - 10 millions units Powder for injections - 300 millions bottles Oral solutions - 50 millions bottles Pellets - 200 millions
  • 11. Major Regulatory Approvals & Audits Chinese GMP approval - 2000 Australian TGA approval (one of the first 4 out of China) - 2005 Leiner’s Audit - 2006 Sigfried’s Audit - 2006 Australian TGA re-inspection approval - 2006 Arrow’s Audit - 2006 Japan Generics’ Audit - 2007 Ratiopharm’s Audit - 2007
  • 12. Chronology of Communications with Leiner Health Products Visits to Leiner - 2005, 2006, 2007 Leiner’s audit – 07/2007 Meeting at CPhI Paris 2006 - Roadmap for 6 OTC products APAP APAP PM Diphenhydramine (capsules & tablets) Aspirin 81mg Aspirin 325mg Prices last updated 07/2007 R&D samples tested and rated by Schuster as 10
  • 13. Working with some leading generic companies in the world since 2003 Currently contract manufacturing 3 products for Australia and New Zealand Developed and ready to sell 9 products to Australia, Japan and Europe Work in process for the first ANDA to be filed in 2009. Embark On International Ventures
  • 14. Why Merro - A first class partner for outsourced products Solid technical and manufacturing experience for cross-board products A top-notch cGMP level Manufacturing capability Proven commercial success Familiarity with business model and respect of the relationship with partners Vision into the future and long-term commitment
  • 15. Merro’s Vision Become the worldwide partner for Chinese domestic and overseas markets, including U.S. market. - Build US presence through Merro Pharmaceutical Corp. - Expand Product Portfolio, including multi ANDAs in phase development. - reinforce the personnel (R&D and Corporate) to secure the sustained development that a leading pharmaceutical firm has to have.
  • 16. MERRO PHARMACETUICAL Existing only For Health